Frontier IP Matthew White joining the Group as Director of Commercialisation

Neil Crabb, Chief Executive of Frontier IP, said: “It is a real pleasure to welcome Matthew to the Frontier IP team. His superb range of skills and experience provide an excellent match for the work many of our portfolio companies are undertaking.”

Frontier IP (LON:FIPP), which specialises in commercialising university intellectual property, today announced that Matthew White, the Head of Innovation at AB Sugar, one of the world’s largest sugar producers and a wholly-owned subsidiary of AB Foods, is joining the Group as Director of Commercialisation, in a non-board role.

Matthew has 23 years’ experience in technology, product and service innovation, business development and marketing. As AB Sugar’s Head of Innovation, he was responsible for defining strategy and managing a global innovation portfolio. The role involved working extensively with university partners on collaborative research programmes totalling over £20million.

Before joining AB Sugar, Matthew was Director of Consumer Products for international technology consulting and product development business Sagentia Limited, working across a wide range of sectors.

He started his career at Neotronics Scientific, one of the first companies to commercialise electronic odour sensing. He has a Natural Sciences degree majoring in Chemistry from the University of Cambridge.

Matthew White, said: “It is fantastic to be joining everyone at Frontier IP. I am looking forward to using my network and experience to accelerate the commercialisation activities of our exciting portfolio.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on linkedin
    LinkedIn
    Frontier IP Group Plc

    More articles like this

    Frontier IP Group Plc

    Animal Lovers and Zoonotic Diseases: 5 Things to Know

    Zoonotic diseases, or zoonoses, are on the rise. That may first bring to mind exotic diseases like Ebola, but the reality is that many zoonotic infections happen closer to home, often during everyday activities. In 2018, we saw

    Frontier IP Group Plc

    AI-based initiatives catalyzing immunotherapy in 2018

    Artificial intelligence (AI) has been dynamically changing the field of drug discovery in several areas, including immunotherapy, oncotherapy, neurological disease, and many more. Described here is an ensemble of the initiatives in place to advance the field of immunotherapy research.

    Frontier IP Group Plc

    Frontier IP Group Plc appoint N+1 Singer as sole broker

    Frontier IP Group PLC (LON:FIPP), a specialist in commercialising university intellectual property, today announced the appointment of Nplus1 Singer Advisory LLP as the Group’s sole broker with immediate effect. Allenby Capital Limited remains the Group’s Nominated Adviser.

    Frontier IP Group Plc

    Britain’s university spinout sector is thriving

    They are among Britain’s greatest national treasures and a powerful engine of ideas and innovation for the nation’s booming technology industry. But how good are UK universities at commercialising the research and expertise which springs from their laboratories

    Frontier IP Group Plc

    Role of Artificial Intelligence in changing the future healthcare

    The major driving force behind the revolution inpatient care is technology. Nowadays, ground-breaking healthcare apps on mobile phones and wearable devices are giving some autonomy to the patients, by increasing their involvement in healthcare, as well as, in

    Frontier IP Group Plc

    Exscientia CEO explains how AI is transforming drug discovery

    In recent decades a strange confluence has formed in the pharmaceutical industry. A range of powerful technologies have brought enormous new capabilities to the sector, productivity has been simultaneously declining. Deloitte’s Centre for Health Solutions estimates that projected returns on investment in pharma

    Frontier IP Group Plc

    How technology is revolutionising the healthcare industry

    A technology revolution is transforming the healthcare industry, changing everything from how patients are diagnosed and treated to our battle against some of the world’s most serious diseases. It’s a revolution fuelled by new sources of healthcare data

    Frontier IP Group Plc

    Artificial Intelligence will Revolutionise Drug Discovery

    New technologies are making their way into the healthcare industry and healthcare providers are already experimenting with advances such as smart pill technology, 3D-printed medication, and mobile apps. But probably the biggest potential lies in artificial intelligence (AI). For